---
figid: PMC3398464__nihms361657f1
figlink: /pmc/articles/PMC3398464/figure/F1/
number: Figure 1
caption: 'Key branches of the insulin signaling cascade. Hypolipidemic and hypoglycemic
  pathways that are normally triggered by insulin are indicated in blue, whereas insulin-stimulated
  pathways that activate lipogenesis and MAP kinases are shown in red. Solid lines
  represent recognized pathways; dotted lines are less well-characterized or putative.
  Pointed arrowheads indicate stimulation of the immediately downstream molecule or
  process; flat arrowheads indicate inhibition. Thus, endpoints that receive signals
  from the insulin receptor via pathways with an even number of flat arrowheads (0
  or 2) are activated by insulin (Gluc uptake, TG-rich lipoprotein clearance, both
  mechanisms for Lipogenesis, Remnant lipoprotein clearance, and phosphorylations
  of ERK). Pathways with an odd number of flat arrowheads are inhibited by insulin
  (PTEN, PTPases, and Gluconeogenesis). Specific sites that become phosphorylated
  (p) upon insulin stimulation are indicated within yellow ovals, and numbers indicate
  residues in human sequences. Lipogenesis-I refers to lipogenesis that becomes activated
  independently from new protein synthesis; Lipogenesis-D depends on new protein synthesis.Abbreviations:
  ACC, acetyl-CoA carboxylase-1; ACL, ATP citrate lyase; AKT/PKB, protein kinase B;
  Apoc3, apolipoprotein C-III; CAV1, caveolin-1; ER, endoplasmic reticulum; ERK, extracellular
  signal-regulated kinase; FOXO1, forkhead box O1A; Gluc, glucose; GLUT translcn,
  translocation of facilitated glucose transporters; GRB2, growth factor receptor-binding
  protein 2; GSK3β, glycogen synthase kinase 3β; HSPG, heparan sulfate proteoglycan;
  IRS, insulin receptor substrate; MEK, MAP/ERK kinase; mTORC, mammalian target of
  rapamycin complex; NOX4, NAD(P)H oxidase 4; PDPK1, 3′-phosphoinositide-dependent
  protein kinase 1; Pepck, phosphoenolpyruvate carboxykinase 1; PI3Ks, isoforms of
  phosphatidylinositol 3′-kinase; PRAS40, proline-rich AKT substrate of 40kDa; PTEN,
  phosphatase and tensin homolog deleted on chromosome 10; PTPases, protein-tyrosine
  phosphatases such as PTP1B; RAF, v-raf-1 murine leukemia viral oncogene homolog
  1; RAS, rat sarcoma guanosine-nucleotide-binding protein; RHEB, RAS homolog enriched
  in brain; S6K1, ribosomal protein S6 kinase 1; SHC, Src homologous and collagen-like
  protein; SOS1, son of sevenless (Drosophila) homolog 1; Srebp1c, sterol regulatory
  element-binding protein-1c, which its discoverers originally named adipocyte determination-
  and differentiation-dependent factor 1 (ADD1); SULF2, heparan sulfate glucosamine-6-O-endosulfatase-2;
  TG, triglyceride; TSC2, tuberin.'
pmcid: PMC3398464
papertitle: The NOX4 pathway as a source of selective insulin resistance and responsiveness.
reftext: Xiangdong Wu, et al. Arterioscler Thromb Vasc Biol. ;32(5):1236-1245.
pmc_ranked_result_index: '215249'
pathway_score: 0.9478111
filename: nihms361657f1.jpg
figtitle: Key branches of the insulin signaling cascade
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3398464__nihms361657f1.html
  '@type': Dataset
  description: 'Key branches of the insulin signaling cascade. Hypolipidemic and hypoglycemic
    pathways that are normally triggered by insulin are indicated in blue, whereas
    insulin-stimulated pathways that activate lipogenesis and MAP kinases are shown
    in red. Solid lines represent recognized pathways; dotted lines are less well-characterized
    or putative. Pointed arrowheads indicate stimulation of the immediately downstream
    molecule or process; flat arrowheads indicate inhibition. Thus, endpoints that
    receive signals from the insulin receptor via pathways with an even number of
    flat arrowheads (0 or 2) are activated by insulin (Gluc uptake, TG-rich lipoprotein
    clearance, both mechanisms for Lipogenesis, Remnant lipoprotein clearance, and
    phosphorylations of ERK). Pathways with an odd number of flat arrowheads are inhibited
    by insulin (PTEN, PTPases, and Gluconeogenesis). Specific sites that become phosphorylated
    (p) upon insulin stimulation are indicated within yellow ovals, and numbers indicate
    residues in human sequences. Lipogenesis-I refers to lipogenesis that becomes
    activated independently from new protein synthesis; Lipogenesis-D depends on new
    protein synthesis.Abbreviations: ACC, acetyl-CoA carboxylase-1; ACL, ATP citrate
    lyase; AKT/PKB, protein kinase B; Apoc3, apolipoprotein C-III; CAV1, caveolin-1;
    ER, endoplasmic reticulum; ERK, extracellular signal-regulated kinase; FOXO1,
    forkhead box O1A; Gluc, glucose; GLUT translcn, translocation of facilitated glucose
    transporters; GRB2, growth factor receptor-binding protein 2; GSK3β, glycogen
    synthase kinase 3β; HSPG, heparan sulfate proteoglycan; IRS, insulin receptor
    substrate; MEK, MAP/ERK kinase; mTORC, mammalian target of rapamycin complex;
    NOX4, NAD(P)H oxidase 4; PDPK1, 3′-phosphoinositide-dependent protein kinase 1;
    Pepck, phosphoenolpyruvate carboxykinase 1; PI3Ks, isoforms of phosphatidylinositol
    3′-kinase; PRAS40, proline-rich AKT substrate of 40kDa; PTEN, phosphatase and
    tensin homolog deleted on chromosome 10; PTPases, protein-tyrosine phosphatases
    such as PTP1B; RAF, v-raf-1 murine leukemia viral oncogene homolog 1; RAS, rat
    sarcoma guanosine-nucleotide-binding protein; RHEB, RAS homolog enriched in brain;
    S6K1, ribosomal protein S6 kinase 1; SHC, Src homologous and collagen-like protein;
    SOS1, son of sevenless (Drosophila) homolog 1; Srebp1c, sterol regulatory element-binding
    protein-1c, which its discoverers originally named adipocyte determination- and
    differentiation-dependent factor 1 (ADD1); SULF2, heparan sulfate glucosamine-6-O-endosulfatase-2;
    TG, triglyceride; TSC2, tuberin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAV1
  - AKT3
  - SREBF1
  - APOC3
  - SULF2
  - AKT1
  - SHC3
  - SHC1
  - IRS2
  - SHC4
  - SOS1
  - SDC2
  - MAPK3
  - AKT1S1
  - MAPK1
  - ACLY
  - SHC2
  - MAP2K2
  - RHEB
  - RPS6KB1
  - PTEN
  - NRAS
  - TSC2
  - SOS2
  - SLC2A1
  - PCK2
  - AKT2
  - FOXD3
  - PDPK1
  - IRS1
  - ACACA
  - GRB2
  - GBA3
  - ACACB
  - ARAF
  - KRAS
  - NOX4
  - BRAF
  - MAP2K1
  - RPTOR
  - RAF1
  - MAPKAP1
  - MLST8
  - HRAS
  - MTOR
  - RICTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: CAV1
  symbol: CAV1
  source: hgnc_symbol
  hgnc_symbol: CAV1
  entrez: '857'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Srebp1c
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: Apoc3
  symbol: APOC3
  source: hgnc_symbol
  hgnc_symbol: APOC3
  entrez: '345'
- word: SULF2
  symbol: SULF2
  source: hgnc_symbol
  hgnc_symbol: SULF2
  entrez: '55959'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: IRS1,2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: GRB2/SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: HSPG
  symbol: HSPG
  source: hgnc_prev_symbol
  hgnc_symbol: SDC2
  entrez: '6383'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: AKT/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ACL
  symbol: ACL
  source: hgnc_alias_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: PTEN,
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: GRB2/SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: Pepck
  symbol: PEPCK
  source: hgnc_alias_symbol
  hgnc_symbol: PCK2
  entrez: '5106'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: genesis
  symbol: Genesis
  source: hgnc_alias_symbol
  hgnc_symbol: FOXD3
  entrez: '27022'
- word: PDPK1
  symbol: PDPK1
  source: hgnc_symbol
  hgnc_symbol: PDPK1
  entrez: '5170'
- word: IRS1,2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: GRB2/SOS
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Gluc
  symbol: GLUC
  source: hgnc_alias_symbol
  hgnc_symbol: GBA3
  entrez: '57733'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NOX4
  symbol: NOX4
  source: hgnc_symbol
  hgnc_symbol: NOX4
  entrez: '50507'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
